Evidence map›Paper›PMID 28199703›Full record

ArticleSchizophrenia bulletin2017

The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.

Melissa A Weibell, Wenche Ten Velden Hegelstad, Bjørn Auestad, Jørgen Bramness, Julie Evensen, Ulrik Haahr, Inge Joa, Jan Olav Johannessen, Tor Ketil Larsen, Ingrid Melle and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Contingency Management for Dually Diagnosed Inpatients with Psychosis.International journal of environmental research and public health · 2024
    Article
  16. The relationship between substance use and self-reported aspects of social functioning in patients with a psychotic disorder.European psychiatry : the journal of the Association of European Psychiatrists · 2024
    Article
  17. Article
  18. Early identification of treatment non-response in first-episode psychosis.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Melissa A WeibellRegional Centre for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway.
Wenche Ten Velden HegelstadRegional Centre for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway.
Bjørn AuestadDepartment of Mathematics and Natural Sciences, University of Stavanger, Stavanger, Norway.
Jørgen BramnessSERAF, Norwegian Centre for Addiction Research, Oslo, Norway.
Julie EvensenDivision of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Ulrik HaahrPsychiatric Research Unit, Zealand Region, Psychiatry East and Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Roskilde, Denmark.
Inge JoaRegional Centre for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway.
Jan Olav JohannessenRegional Centre for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway.
Tor Ketil LarsenRegional Centre for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway.
Ingrid MelleInstitute of Psychiatry, Faculty of Medicine, University of Oslo, Oslo, Norway.
Stein OpjordsmoenInstitute of Psychiatry, Faculty of Medicine, University of Oslo, Oslo, Norway.
Bjørn Rishovd RundDepartment of Psychology, University of Oslo, Oslo, Norway.
Erik SimonsenPsychiatric Research Unit, Zealand Region, Psychiatry East and Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Roskilde, Denmark.
Per VaglumInstitute of Psychiatry, Faculty of Medicine, University of Oslo, Oslo, Norway.
Thomas McGlashanDepartment of Psychiatry, Yale University, New Haven, CT.
Patrick McGorryOrygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.
Svein FriisInstitute of Psychiatry, Faculty of Medicine, University of Oslo, Oslo, Norway.
Stavanger University Hospital · NOUniversity of Oslo · NOOslo University Hospital · NOUniversity of Copenhagen · DKUniversity of Stavanger · NONORCE Norwegian Research Centre · NOOrygen Youth Health · AUUniversity of Bergen · NOVestre Viken Hospital Trust · NOYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance use is common in first-episode psychosis (FEP) and has been linked to poorer outcomes with more severe psychopathology and higher relapse rates. Early substance discontinuation appears to improve symptoms and function. However, studies vary widely in their methodology, and few have examined patients longitudinally, making it difficult to draw conclusions for practice and treatment. We aimed to investigate the relationship between substance use and early abstinence and the long-term course of illness in a representative sample of FEP patients. Out of 301 included patients, 266 could be divided into 4 groups based on substance use patterns during the first 2 years of treatment: persistent users, episodic users, stop-users and nonusers. Differences in clinical and functional measures during the follow-up period were assessed using linear mixed effects models for the analysis of repeated measures data. Patients who stopped using substances within the first 2 years after diagnosis had outcomes similar to those who had never used with fewer symptoms than episodic or persistent users. Both episodic and persistent users had lower rates of symptom remission than nonusers, and persistent users also had more negative symptoms than those who stopped using. Our findings emerge from one of very few long-term longitudinal studies examining substance use cessation in FEP with 10-year follow-up. The results convey hope that the detrimental effects of substance abuse on mental health may be significantly reversed if one stops the abuse in time. This can help patients who struggle with addiction with their motivation to embrace abstinence.

Indexed as

Disease ProgressionAdolescentAdultAgedDenmarkFemaleHumansLongitudinal StudiesMaleMiddle AgedNorwayOutcome Assessment, Health CarePsychotic DisordersSchizophreniaSubstance-Related DisordersYoung Adultnegative symptomspsychosisschizophreniasubstance abuse

Identifiers

PMID28199703
PMCPMC5472130
OpenAlexW2588619753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.